2024 Q2 Form 10-Q Financial Statement

#000107997324000724 Filed on May 15, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q1
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $526.6K $838.0K
YoY Change -37.16% 110.69%
% of Gross Profit
Research & Development $6.144K $24.24K
YoY Change -74.66% -17.57%
% of Gross Profit
Depreciation & Amortization $331.00 $461.00
YoY Change -28.2% 84.4%
% of Gross Profit
Operating Expenses $533.1K $883.7K
YoY Change -39.67% 106.76%
Operating Profit -$533.1K -$883.7K
YoY Change -39.67% 106.76%
Interest Expense -$4.050K $25.83K
YoY Change -115.68% -151.64%
% of Operating Profit
Other Income/Expense, Net -$5.026K $25.83K
YoY Change -119.46% -96.97%
Pretax Income -$538.2K -$857.9K
YoY Change -37.27% -301.83%
Income Tax
% Of Pretax Income
Net Earnings -$538.1K -$857.9K
YoY Change -37.27% -301.57%
Net Earnings / Revenue
Basic Earnings Per Share -$0.01 -$0.02
Diluted Earnings Per Share -$0.01 -$0.02
COMMON SHARES
Basic Shares Outstanding 56.52M shares 56.20M shares 43.63M shares
Diluted Shares Outstanding 54.04M shares 45.46M shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $49.74K $1.613M
YoY Change -96.92% -55.22%
Cash & Equivalents $52.21K $49.74K $1.613M
Short-Term Investments
Other Short-Term Assets $127.3K $119.1K
YoY Change 6.87% 132.3%
Inventory
Prepaid Expenses $16.72K $121.3K $113.1K
Receivables
Other Receivables
Total Short-Term Assets $74.94K $177.0K $1.732M
YoY Change -88.45% -89.78% -61.98%
LONG-TERM ASSETS
Property, Plant & Equipment $695.00 $9.342M $5.788M
YoY Change -99.99% 61.39% 190.53%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $37.32K $9.393M $5.895M
YoY Change -99.46% 59.33% 195.9%
TOTAL ASSETS
Total Short-Term Assets $74.94K $177.0K $1.732M
Total Long-Term Assets $37.32K $9.393M $5.895M
Total Assets $112.3K $9.570M $7.627M
YoY Change -98.52% 25.47% 16.48%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.719M $800.9K
YoY Change 239.47% -34.24%
Accrued Expenses $53.98K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $261.1K
YoY Change
Total Short-Term Liabilities $5.758M $4.467M $1.585M
YoY Change 256.09% 181.77% -9.08%
LONG-TERM LIABILITIES
Long-Term Debt $1.711M $1.736M
YoY Change -1.4% -66.12%
Other Long-Term Liabilities $0.00 $120.0K
YoY Change -100.0% -4.57%
Total Long-Term Liabilities $1.711M $1.855M
YoY Change -7.77% -64.65%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.758M $4.467M $1.585M
Total Long-Term Liabilities $1.711M $1.855M
Total Liabilities $5.883M $6.178M $3.441M
YoY Change 74.99% 79.55% -51.06%
SHAREHOLDERS EQUITY
Retained Earnings -$138.9M -$129.2M -$126.6M
YoY Change 9.19% 2.12%
Common Stock $0.00 $0.00 $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$5.809M $3.355M $4.149M
YoY Change
Total Liabilities & Shareholders Equity $112.3K $9.570M $7.627M
YoY Change -98.52% 25.47% 16.48%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q1
OPERATING ACTIVITIES
Net Income -$538.1K -$857.9K
YoY Change -37.27% -301.57%
Depreciation, Depletion And Amortization $331.00 $461.00
YoY Change -28.2% 84.4%
Cash From Operating Activities -$304.5K -$559.3K
YoY Change -45.56% 106.5%
INVESTING ACTIVITIES
Capital Expenditures $206.1K $1.664M
YoY Change -87.62% -254.76%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$206.1K -$1.664M
YoY Change -87.62% 54.76%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 175.6K 2.735M
YoY Change -93.58%
NET CHANGE
Cash From Operating Activities -304.5K -559.3K
Cash From Investing Activities -206.1K -1.664M
Cash From Financing Activities 175.6K 2.735M
Net Change In Cash -335.0K 511.5K
YoY Change -165.49% -138.0%
FREE CASH FLOW
Cash From Operating Activities -$304.5K -$559.3K
Capital Expenditures $206.1K $1.664M
Free Cash Flow -$510.6K -$2.223M
YoY Change -77.04% -376.39%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 bnet Options Exercised Under Cashless Exercise
OptionsExercisedUnderCashlessExercise
usd
CY2024Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
usd
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2024Q1 bnet Warrants Exercised Under Cashless Exercise
WarrantsExercisedUnderCashlessExercise
usd
CY2024Q1 bnet Adjustment To Additional Paid In Capital Modification Of Warrants
AdjustmentToAdditionalPaidInCapitalModificationOfWarrants
usd
bnet Warrants Exercised Under Cashless Exercise
WarrantsExercisedUnderCashlessExercise
usd
bnet Options Exercised Under Cashless Exercise
OptionsExercisedUnderCashlessExercise
usd
dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
56522939 shares
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
625964 usd
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
16785 usd
CY2023Q2 us-gaap Deposits Assets Current
DepositsAssetsCurrent
6000 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
648749 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
93875 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6851009 usd
CY2023Q2 us-gaap Assets
Assets
7593633 usd
CY2023Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
677136 usd
CY2023Q2 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
864781 usd
CY2023Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
0 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
53977 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
75000 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
4466560 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1616917 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
29068 usd
CY2024Q1 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
1711224 usd
CY2023Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
1715970 usd
CY2024Q1 us-gaap Liabilities
Liabilities
6177784 usd
CY2023Q2 us-gaap Liabilities
Liabilities
3361955 usd
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
57219930 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
48044790 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
56515621 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
47340480 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
0 usd
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
0 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
133098463 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
131935418 usd
CY2024Q1 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
504650 usd
CY2023Q2 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
504650 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-129238944 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-127236663 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
3354869 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
4194105 usd
CY2024Q1 us-gaap Minority Interest
MinorityInterest
37573 usd
CY2023Q2 us-gaap Minority Interest
MinorityInterest
37573 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3392442 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4231678 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9570226 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7593633 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
0 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
0 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
0 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
0 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
526644 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
859011 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1828917 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2356047 usd
CY2024Q1 us-gaap Depreciation
Depreciation
331 usd
CY2023Q1 us-gaap Depreciation
Depreciation
461 usd
us-gaap Depreciation
Depreciation
1251 usd
us-gaap Depreciation
Depreciation
1185 usd
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6144 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
24242 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
21873 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
67833 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
533119 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
883714 usd
us-gaap Operating Expenses
OperatingExpenses
1852041 usd
us-gaap Operating Expenses
OperatingExpenses
2425065 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-533119 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-883714 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1852041 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-2425065 usd
us-gaap Interest Income Operating
InterestIncomeOperating
611 usd
us-gaap Interest Income Operating
InterestIncomeOperating
4652 usd
CY2024Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
972 usd
CY2023Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
0 usd
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
972 usd
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
0 usd
CY2024Q1 bnet Interests Expense
InterestsExpense
4161 usd
CY2023Q1 bnet Interests Expense
InterestsExpense
-24488 usd
bnet Interests Expense
InterestsExpense
149879 usd
bnet Interests Expense
InterestsExpense
86892 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-5026 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
25830 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-150240 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-82240 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-538145 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-857884 usd
us-gaap Net Income Loss
NetIncomeLoss
-2002281 usd
us-gaap Net Income Loss
NetIncomeLoss
-2507305 usd
CY2024Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-0 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-0 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-0 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-0 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-538145 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-857884 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2002281 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2507305 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3392442 usd
us-gaap Net Income Loss
NetIncomeLoss
-2002281 usd
us-gaap Net Income Loss
NetIncomeLoss
-2507305 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1251 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1185 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
54035865 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
54035865 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45456417 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45456417 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50498173 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50498173 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44165309 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
44165309 shares
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1536874 usd
CY2023Q1 bnet Sale Of Units Value
SaleOfUnitsValue
2720000 usd
CY2023Q1 bnet Warrants Exercised For Common Shares
WarrantsExercisedForCommonShares
63000 usd
CY2023Q1 bnet Issuance Of Warrants For Services
IssuanceOfWarrantsForServices
9844 usd
CY2023Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
99889 usd
CY2023Q1 bnet Vesting Of Options For Employees And Services
VestingOfOptionsForEmployeesAndServices
220510 usd
CY2023Q1 bnet Stock Issued During Period Value Commissions On Sale Of Units
StockIssuedDuringPeriodValueCommissionsOnSaleOfUnits
-48000 usd
CY2023Q1 bnet Debt Modification
DebtModification
3516345 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-857885 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4186829 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3631047 usd
CY2024Q1 bnet Sale Of Units Value
SaleOfUnitsValue
190000 usd
CY2024Q1 bnet Issuance Of Warrant For Services Value
IssuanceOfWarrantForServicesValue
30000 usd
CY2024Q1 bnet Vesting Of Options For Employees And Services
VestingOfOptionsForEmployeesAndServices
52378 usd
CY2024Q1 bnet Vesting Of Warrants For Employees And Services
VestingOfWarrantsForEmployeesAndServices
3281 usd
CY2024Q1 bnet Debt Modification Value
DebtModificationValue
-11122 usd
CY2024Q1 bnet Conversion Of Debt And Liabilities Value
ConversionOfDebtAndLiabilitiesValue
49403 usd
CY2024Q1 bnet Stock Issued During Period Value Commission On Sale Of Units
StockIssuedDuringPeriodValueCommissionOnSaleOfUnits
-14400 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-538145 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3392442 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-894579 usd
bnet Sale Of Units Value
SaleOfUnitsValue
3266230 usd
bnet Warrants Exercised For Common Shares
WarrantsExercisedForCommonShares
119125 usd
bnet Issuance Of Units For Services
IssuanceOfUnitsForServices
80000 usd
bnet Issuance Of Warrant For Services Value
IssuanceOfWarrantForServicesValue
57094 usd
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
149889 usd
bnet Vesting Of Options For Employees And Services
VestingOfOptionsForEmployeesAndServices
220510 usd
bnet Stock Issued During Period Value Commissions On Sale Of Units
StockIssuedDuringPeriodValueCommissionsOnSaleOfUnits
-48000 usd
bnet Adjustment To Additional Paid In Capital Modification Of Warrants Non Cash
AdjustmentToAdditionalPaidInCapitalModificationOfWarrantsNonCash
159433 usd
bnet Modification Of Warrants Interest
ModificationOfWarrantsInterest
68088 usd
bnet Debt Modifications Value
DebtModificationsValue
3516345 usd
us-gaap Profit Loss
ProfitLoss
-2507305 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4186829 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4231678 usd
bnet Sale Of Units Value
SaleOfUnitsValue
610742 usd
bnet Warrants Exercised For Common Shares
WarrantsExercisedForCommonShares
28500 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
76320 usd
bnet Issuance Of Warrant For Services Value
IssuanceOfWarrantForServicesValue
35000 usd
bnet Vesting Of Options For Employees And Services
VestingOfOptionsForEmployeesAndServices
159865 usd
bnet Vesting Of Warrants For Employees And Services
VestingOfWarrantsForEmployeesAndServices
9844 usd
bnet Debt Modification Value
DebtModificationValue
-27983 usd
bnet Conversion Of Debt And Liabilities Value
ConversionOfDebtAndLiabilitiesValue
140951 usd
bnet Adjustment To Additional Paid In Capital Modification Of Warrants
AdjustmentToAdditionalPaidInCapitalModificationOfWarrants
150206 usd
bnet Commission On Sale Of Units
CommissionOnSaleOfUnits
-20400 usd
us-gaap Profit Loss
ProfitLoss
-2002281 usd
us-gaap Other Noncash Expense
OtherNoncashExpense
149879 usd
us-gaap Other Noncash Expense
OtherNoncashExpense
86891 usd
us-gaap Share Based Compensation
ShareBasedCompensation
184709 usd
us-gaap Share Based Compensation
ShareBasedCompensation
220510 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
106321 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
80000 usd
bnet Modification Of Warrants
ModificationOfWarrants
0 usd
bnet Modification Of Warrants
ModificationOfWarrants
154932 usd
us-gaap Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
5000 usd
us-gaap Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
57094 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
104497 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-44449 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-0 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
5000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
285420 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-908644 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-7788 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
29712 usd
us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
626834 usd
us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
265000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-755152 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2481176 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
689919 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2403644 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-689919 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2403644 usd
bnet Proceeds From Sale Of Units
ProceedsFromSaleOfUnits
610742 usd
bnet Proceeds From Sale Of Units
ProceedsFromSaleOfUnits
3266230 usd
bnet Commissions On Sale Of Units
CommissionsOnSaleOfUnits
20400 usd
bnet Commissions On Sale Of Units
CommissionsOnSaleOfUnits
48000 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
250000 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
28500 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
119125 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
868842 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3337355 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-576229 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-1547465 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
625964 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3160442 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
49735 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1612977 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
bnet Conversion Of Debt And Liabilities Into Common Units
ConversionOfDebtAndLiabilitiesIntoCommonUnits
140951 usd
bnet Conversion Of Debt And Liabilities Into Common Units
ConversionOfDebtAndLiabilitiesIntoCommonUnits
149888 usd
bnet Conversion Of Debt And Liabilities Into Notes Payable
ConversionOfDebtAndLiabilitiesIntoNotesPayable
0 usd
bnet Conversion Of Debt And Liabilities Into Notes Payable
ConversionOfDebtAndLiabilitiesIntoNotesPayable
23943 usd
bnet Conversion Of Deferred Compensation To Notes Payable
ConversionOfDeferredCompensationToNotesPayable
80767 usd
bnet Conversion Of Deferred Compensation To Notes Payable
ConversionOfDeferredCompensationToNotesPayable
90000 usd
bnet Capitalized Interest In Property And Equipment
CapitalizedInterestInPropertyAndEquipment
45676 usd
bnet Capitalized Interest In Property And Equipment
CapitalizedInterestInPropertyAndEquipment
117342 usd
bnet Purchase Of Property And Equipment For Accounts Payable
PurchaseOfPropertyAndEquipmentForAccountsPayable
1756285 usd
bnet Purchase Of Property And Equipment For Accounts Payable
PurchaseOfPropertyAndEquipmentForAccountsPayable
372844 usd
CY2024Q1 bnet Liability Current
LiabilityCurrent
4500000 usd
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
2800000 usd
CY2024Q1 bnet Increase In Deferred Compensation
IncreaseInDeferredCompensation
2000000 usd
CY2023Q4 bnet Initial Tranche
InitialTranche
250000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
2002000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
2507000 usd
CY2024Q1 bnet Working Capital Deficit
WorkingCapitalDeficit
4290000 usd
us-gaap Stockholders Equity Other
StockholdersEquityOther
3355000 usd
CY2022 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
8291000 usd
CY2023 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
3189000 usd
CY2022 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
10235000 usd
CY2022 bnet Gain On Sale Of Domain Amount
GainOnSaleOfDomainAmount
902000 usd
CY2023 bnet Reduction Of Debt
ReductionOfDebt
3516000 usd
CY2024Q1 bnet Liability Current
LiabilityCurrent
4500000 usd
CY2023Q1 bnet Liability Current
LiabilityCurrent
1600000 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
2900000 usd
CY2023 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
4038000 usd
CY2022 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
1737000 usd
CY2023 bnet Payments To Warrant Exercises Commissions
PaymentsToWarrantExercisesCommissions
86000 usd
CY2022 bnet Payments To Warrant Exercises Commissions
PaymentsToWarrantExercisesCommissions
19000 usd
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
611000 usd
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
3266000 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
250000 usd
CY2023Q4 bnet Deferred Compensation Liability Amount Cancelled
DeferredCompensationLiabilityAmountCancelled
1250000 usd
CY2018 bnet Deferred Compensation Liability Amount Cancelled
DeferredCompensationLiabilityAmountCancelled
2404000 usd
bnet Reduction Of Debt
ReductionOfDebt
3516000 usd
CY2024Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2023Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_84A_eus-gaap--ConcentrationRiskCreditRisk_zJ95DauuT145" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_86B_zmEOvA7cbuwc">Concentrations of credit risk:</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company's financial instruments that are exposed to concentrations of credit risk consist of cash. The Company's cash is in demand deposit accounts placed with federally insured financial institutions and selected brokerage accounts. Such deposit accounts at times may exceed federally insured limits. The Company has not experienced any losses on such accounts.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
5000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0
CY2024Q1 bnet Shares Issued Beginning Of Period
SharesIssuedBeginningOfPeriod
50611962 shares
CY2023Q1 bnet Shares Issued Beginning Of Period
SharesIssuedBeginningOfPeriod
44529884 shares
bnet Shares Issued Beginning Of Period
SharesIssuedBeginningOfPeriod
48880237 shares
bnet Shares Issued Beginning Of Period
SharesIssuedBeginningOfPeriod
43758820 shares
CY2024Q1 bnet Shares Held By Subsidiaries
SharesHeldBySubsidiaries
-704309 shares
CY2023Q1 bnet Shares Held By Subsidiaries
SharesHeldBySubsidiaries
-704309 shares
bnet Shares Held By Subsidiaries
SharesHeldBySubsidiaries
-704309 shares
bnet Shares Held By Subsidiaries
SharesHeldBySubsidiaries
-704309 shares
CY2024Q1 bnet Shares Outstanding Beginning Of Period
SharesOutstandingBeginningOfPeriod
49907653 shares
CY2023Q1 bnet Shares Outstanding Beginning Of Period
SharesOutstandingBeginningOfPeriod
43825575 shares
bnet Shares Outstanding Beginning Of Period
SharesOutstandingBeginningOfPeriod
48175928 shares
bnet Shares Outstanding Beginning Of Period
SharesOutstandingBeginningOfPeriod
43054511 shares
CY2024Q1 bnet Weighted Average Shares Issued During Period
WeightedAverageSharesIssuedDuringPeriod
4128212 shares
CY2023Q1 bnet Weighted Average Shares Issued During Period
WeightedAverageSharesIssuedDuringPeriod
1630842 shares
bnet Weighted Average Shares Issued During Period
WeightedAverageSharesIssuedDuringPeriod
2322245 shares
bnet Weighted Average Shares Issued During Period
WeightedAverageSharesIssuedDuringPeriod
1110798 shares
CY2024Q1 bnet Weighted Average Number Of Diluted Share Outstanding
WeightedAverageNumberOfDilutedShareOutstanding
54035865 shares
CY2023Q1 bnet Weighted Average Number Of Diluted Share Outstanding
WeightedAverageNumberOfDilutedShareOutstanding
45456417 shares
bnet Weighted Average Number Of Diluted Share Outstanding
WeightedAverageNumberOfDilutedShareOutstanding
50498173 shares
bnet Weighted Average Number Of Diluted Share Outstanding
WeightedAverageNumberOfDilutedShareOutstanding
44165309 shares
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_840_eus-gaap--UseOfEstimates_zcAuXFOJ4MDl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_860_zUtjQR6FlqYa">Use of estimates:</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In preparing the Company’s condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p>
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
12006600 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.85
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P1Y9M29D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
5085659 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2024Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
9353218 usd
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6862916 usd
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
11581 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
11907 usd
CY2024Q1 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
9341637 usd
CY2023Q2 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
6851009 usd
us-gaap Interest Costs Capitalized
InterestCostsCapitalized
257657 usd
us-gaap Interest Costs Capitalized
InterestCostsCapitalized
98104 usd
bnet Non Cash Compensation
NonCashCompensation
135648 usd
bnet Non Cash Compensation
NonCashCompensation
135648 usd
CY2024Q1 us-gaap Depreciation
Depreciation
331 usd
CY2023Q1 us-gaap Depreciation
Depreciation
461 usd
us-gaap Depreciation
Depreciation
1251 usd
us-gaap Depreciation
Depreciation
1185 usd
CY2024Q1 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
1432678 usd
CY2023Q1 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
784255 usd
CY2021Q2 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
9868495 usd
CY2024Q1 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.50
us-gaap Costs Incurred Development Costs
CostsIncurredDevelopmentCosts
45675 usd
us-gaap Costs Incurred Development Costs
CostsIncurredDevelopmentCosts
117342 usd
CY2023Q1 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
3470000 usd
CY2023Q4 bnet Initial Tranche
InitialTranche
250000 usd
CY2023Q1 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
3470000 usd
CY2023 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
3522000 usd
CY2023 bnet Reduction Of Additional Paid In Capital
ReductionOfAdditionalPaidInCapital
14051 usd
bnet Reduction Of Additional Paid In Capital
ReductionOfAdditionalPaidInCapital
27982 usd
bnet Shares Held By Subsidiaries
SharesHeldBySubsidiaries
-704309 shares
bnet Class Of Warrant Or Right Exercised During Period
ClassOfWarrantOrRightExercisedDuringPeriod
38000 shares
bnet Common Stock Shares Issued Upon Exercise Of Warrants
CommonStockSharesIssuedUponExerciseOfWarrants
38000 shares
bnet Total Proceeds
TotalProceeds
28500 usd
CY2024Q1 bnet Exercise Bonus
ExerciseBonus
0.75 pure
CY2024Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
17500000 shares
CY2023Q3 bnet Sale Of Warrants
SaleOfWarrants
1003590 shares
CY2023Q3 us-gaap Warrant Exercise Price Increase
WarrantExercisePriceIncrease
1.25
CY2023Q3 us-gaap Shares Issued
SharesIssued
501795 shares
CY2023Q3 us-gaap Warrants And Rights Outstanding Maturity Date
WarrantsAndRightsOutstandingMaturityDate
2023-10-01
bnet Class Of Warrant Or Right Exercised During Period
ClassOfWarrantOrRightExercisedDuringPeriod
38000 shares
bnet Common Stock Shares Issued Upon Exercise Of Warrants
CommonStockSharesIssuedUponExerciseOfWarrants
38000 shares
bnet Warrants Exercised For Common Stock
WarrantsExercisedForCommonStock
28500 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
50000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
11951600 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.85
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P1Y29D
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1379033 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
0 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
0 usd
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
0 usd
CY2022Q2 bnet Compensation Increased
CompensationIncreased
25000 usd
CY2021Q2 bnet Exercise Bonus
ExerciseBonus
0.75 pure
CY2021Q2 bnet Warrants Held By Trust Owned Shares
WarrantsHeldByTrustOwnedShares
3000000 shares
CY2024Q1 bnet Warrants And Rights Outstanding Shares
WarrantsAndRightsOutstandingShares
14640181 shares
CY2022Q1 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
2665500 usd
CY2022Q1 us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.25 pure
CY2022Q1 us-gaap Debt Instrument Periodic Payment
DebtInstrumentPeriodicPayment
666375 usd
CY2022Q2 us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.25 pure
CY2022Q1 us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.25 pure
CY2023Q1 us-gaap Debt Instrument Periodic Payment
DebtInstrumentPeriodicPayment
533100 usd
CY2023Q2 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
83275 usd
CY2023Q2 bnet Aggregate Payment
AggregatePayment
2615500 usd
CY2022Q2 bnet Purchase Order
PurchaseOrder
50000 usd
us-gaap Interest Costs Incurred Capitalized
InterestCostsIncurredCapitalized
6675112 usd
bnet Interest Costs Capitalized Paid
InterestCostsCapitalizedPaid
7191021 usd
us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
1756285 usd
bnet Interests Costs Incurred Capitalized
InterestsCostsIncurredCapitalized
8346895 usd
CY2024Q1 bnet Operating Leases Future Minimum Payment Receivable In Two Years
OperatingLeasesFutureMinimumPaymentReceivableInTwoYears
56250 usd
CY2024Q1 bnet Undiscounted Cash Flow
UndiscountedCashFlow
56250 usd
CY2024Q1 bnet Less Imputed Interest
LessImputedInterest
-2274 usd
CY2024Q1 bnet Capital Lease Contingent Rental Payments Due
CapitalLeaseContingentRentalPaymentsDue
53976 usd
CY2023Q4 bnet Initial Tranche
InitialTranche
250000 usd
bnet Sale Of Domain Description
SaleOfDomainDescription
the Company entered into an agreement to sell domain name <biontech.com> and other related assets to BioNTech SE (“BNTX”) for the sum of $950,000 (before expenses related to the transaction) which sale was closed/completed on April 2, 2022 with a one-time gain of $902,490.
CY2021Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
2255802 usd
CY2021Q4 us-gaap Assets
Assets
297 usd
CY2021Q4 us-gaap Liabilities
Liabilities
10154334 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
9939148 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
214235 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
950 usd
CY2021Q4 us-gaap Liabilities
Liabilities
10234501 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
10009802 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
212263 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
12436 usd
us-gaap Gain Or Loss On Sale Of Stock In Subsidiary
GainOrLossOnSaleOfStockInSubsidiary
10234501 usd
CY2021Q2 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
9868495 usd
CY2023Q2 bnet Bank Account Hacked Amount
BankAccountHackedAmount
75000 usd
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001079973-24-000724-index-headers.html Edgar Link pending
0001079973-24-000724-index.html Edgar Link pending
0001079973-24-000724.txt Edgar Link pending
0001079973-24-000724-xbrl.zip Edgar Link pending
bion_10q-033124.htm Edgar Link pending
bnet-20240331.xsd Edgar Link pending
ex31x1.htm Edgar Link pending
ex31x2.htm Edgar Link pending
ex32x1.htm Edgar Link pending
ex32x2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
bnet-20240331_def.xml Edgar Link unprocessable
bion_10q-033124_htm.xml Edgar Link completed
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
bnet-20240331_lab.xml Edgar Link unprocessable
bnet-20240331_cal.xml Edgar Link unprocessable
bnet-20240331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable